Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Response Related to IMmune Age T Cell Fitness in Elderly Patients With Relapsed and Refractory Multiple Myeloma

NCT07674498 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT07674498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07674498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Response Related to IMmune Age T Cell Fitness in Elderly Patients With Relapsed and Refractory Multiple Myeloma
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Recruiting
Start date
June 3, 2026
Completion date
September 30, 2027
Enrollment
31 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma multiple